New Challenges in the Management of Heart Failure: Meet the Experts

  • Views:

    Views Icon 329
  • Likes:

    Heart Icon 2


This online clinical academic event will focus on recent advances in the management of heart failure. The event consists of two online webinars on consecutive days of approximately 2 hours in duration each.

As the focus of the programme is on practical management of heart failure, the webinar sessions will be based on exemplary clinical cases and guideline recommendations to provide the attendees with up to date expert opinion on the different aspects of pharmacological treatment of heart failure.

All Faculty members are experts of international calibre with extensive clinical and research networks worldwide. Most of them have contributed to the development of national and international management guidelines.

Moderated By:

Juan Carlos Kaski

Juan Carlos Kaski

Giuseppe Rosano, MD

Giuseppe Rosano, MD

Alexander Lyon

Alexander Lyon

Andrew JS Coats

Andrew JS Coats

This webinar is supported by:


12:00 - 12:15

Welcome and introduction-Juan Carlos Kaski & Giuseppe Rosano

12:15 - 12:45

HFpEF - Diagnosis, differences, risk stratification and management - An overview. -Alexander Lyon

12:45 - 13:15

Management of HFrEF - Current guidelines and beyond. -Andrew Coats

13:15 - 13:45

Practical issues in the management of heart failure - comorbidities - FAQ -Panel discussion – Andrew Coats, Alexander Lyon, Giuseppe Rosano

Learning objectives

  • To gain insight into the most recent developments in the pathophysiology of different forms of heart failure, including HFpEF and HFrEF.
  • To briefly discuss non-cardiac treatments affecting heart function i.e. oncological treatments.
  • To discuss current international management guidelines and their application to specific cases.
  • To gain insight into the management of heart failure patients affected by different co-morbidities such as diabetes and chronic kidney disease.
  • To present and discuss the management of iron deficiency and frailty in heart failure.


  • The webinar is aimed at cardiac consultants, diabetologists, vascular surgeons, renal physicians, general practitioners with an interest in cardiovascular disease, specialist nurses and other health professionals involved in heart failure, cardiovascular

Faculty Biographies

Juan Carlos Kaski

Juan Carlos Kaski

Juan Carlos Kaski is Professor of Cardiovascular Science (Emeritus) at the Molecular and Clinical Sciences Research Institute, St Gorge’s, University of London, and Hon. Consultant Cardiologist at St George’s Hospital and the Royal Brompton Hospital in London, UK.  He is Doctor Honoris Causa of several universities worldwide, a past-President of the International Society of Cardiovascular Pharmacotherapy and Fellow of over 30 scientific societies worldwide. JC Kaski has received numerous national and international awards for his research work and both his clinical and educational activities. Professor Kaski is Chairman-elect, European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy, Editor-in-Chief of the European Cardiology Review Journal, Deputy Editor of the European Heart Journal, Co-Editor of the ESC Handbook on Cardiovascular Pharmacotherapy and editorial board member of JACC and over 20 other scientific journals. Prof Kaski’s research areas include inflammatory and immunological mechanisms of atherosclerosis, microvascular and vasospastic angina, INOCA and MINOCA, biomarkers of cardiovascular risk and management of angina pectoris. He has authored over 600 scientific papers on these topics in peer review journals and edited 10 books.

Professor Juan Carlos Kaski is Editor-In-Chief of the European Cardiology Review.

View full profile
Giuseppe Rosano, MD

Giuseppe Rosano, MD

Giuseppe Rosano is Consultant Cardiologist and Professor of Cardiology at St George’s, University of London where he is also the director of MSc Heart Failure.

After obtaining his MD in Medicine and Surgery at the La Sapienza University of Rome, Prof Rosano obtained his specialisation in cardiology from the same University before attaining his PhD in Medical Sciences from Imperial College London. His research interests focus on experimental and clinical pharmacology, heart failure, cardiac metabolism, diabetes and gender differences in cardiovascular diseases.

Prof Rosano has been core member of the Cardiovascular Working Party of the European Medicines Agency and member of the Pricing and Reimbursement Committee of the Italian Drug Agency. He is the President-Elect of the Heart Failure Association Board (HFA), and Chairman of the Education Committee of the HFA. Prof Rosano is on the editorial board for European Journal of Heart Failure, European Heart Journal CV Pharmacotherapy, Cardiac Failure Reviews and Cardiovascular Diabetology. He has authored over 500 peer-reviewed articles, eight books and 32 book chapters.

Dr Giuseppe Rosano is Deputy Editor-in-Chief of Cardiac Failure Review.

View full profile
Alexander Lyon

Alexander Lyon

Dr Alexander Lyon is a leading London-based consultant cardiologist, specialising in the field of heart failure, cardiomyopathy, cardio-oncology and takotsubo syndrome. He is highly experienced, and is well-versed in all aspects of cardiology. Along with his private clinics at Royal Brompton Hospital and in central London, he is also senior lecturer for the National Heart and Lung Institute at Imperial College London.

Dr Lyon graduated with a first class degree from Oxford University, and gained experience doing post-graduate training in London and Sydney before setting up private practice in London. He also holds a PhD. He is renowned for his research into heart failure and takotsubo syndrome, and is lead for the heart failure research theme of the Biomedical Research Unit at the Royal Brompton Hospital, funded by the National Institute of Health Research.

Dr Alexander Lyon is an Editorial Board member of Cardiac Failure Review.

View full profile
Andrew JS Coats

Andrew JS Coats

Personal History6

Professor Andrew Justin Stewart Coats was born in Melbourne, Australia on 1 February 1958. His father was a Professor of Resuscitation who first described essential fatty acids.

He is an Australian-British academic cardiologist as well as a successful fundraiser, university administrator and inventor. 


Academic History

Professor Coats attended Melbourne Grammar School and studied at Oxford and Cambridge.9 He has higher doctorates from Oxford (DM) and Imperial (DSc.) and an MBA from London Business School.1 

He obtained a Bachelor of Arts in 1979, a Bachelor of Medicine and Surgery in 1981, a Master of Arts in 1982, a PhD in Management in 1989, became a Doctor of Sciences in 1999 and completed a further Masters in Business Administration in 2001.

He is a Diplomate and Fellow of the Australian Institute of Company Directors and a member of the UK Institute of Directors.1 Professor Coats’ research interests are chronic heart failure, hypertension and organizational behaviour. 

His research has greatly influenced the treatment for chronic heart failure, promoting exercise training instead of bed rest. He was instrumental in describing the "muscle hypothesis" of heart failure. This research turned established teaching on its head and promoted exercise training (rather than bed rest) as a treatment for chronic heart failure.3


Career Overview

After completing his medical degree in 1981, Andrew Coats began his career at St Vincent's Hospital, Melbourne. Ten years later, he was appointed Senior Lecturer, supported by the British Heart Foundation, at the National Heart and Lung Institute (NHLI). He was appointed Viscount Royston Professor of Cardiology at Imperial College in 1996 and Director of Cardiology and Associate Medical Director of the Royal Brompton and Harefield NHS trust.9 He was also an honorary consultant physician, Clinical Director for Cardiology and Associate Medical Director at the Royal Brompton Hospital in London.

Professor Coats was appointed Dean of Medicine at the University of Sydney in 2002 and subsequently Deputy Vice-Chancellor.4 Professor Coats was CEO of Norwich Research Park, the UK's oldest and largest research and innovation park. In 2009, Professor Coats was appointed the second Norwich Research Park Professor-at-Large. Concurrently, he was Visiting Professor of Medicine at The University of Sydney in Australia, Consulting Professor for Research Strategy at the Chinese University of Hong Kong and a Guest Scientist at the Charité Medical School of Humboldt University in Berlin.8

In 2017, he was appointed an Officer of the Order of Australia for distinguished service to medical research and tertiary education in the field of cardiology, as an academic and author and as a mentor and role model for young scientists.10 

He was the chair of Australia's peak policy body for Health Informatics, the Australian Health Information Council, the New South Wales Ministerial Advisory Committee on Health and Medical Research (MACMHR) and has been on various committees.4 Professor Coats has published two theses, 15 Government reports, 10 textbooks, two Cochrane reviews, over 500 peer-reviewed full papers and has more than 49,000 career citations.5

Professor Coats has both chaired and been a committee member of many large-scale international drug trials that have influenced the treatment of cardiovascular diseases such as the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Trial, OPTIMAAL (angiotensin receptor antagonist in heart failure) and SENIORS (management of heart failure in the elderly).

He has been a board director of a number of private and public companies such as Myotec, PsiOxus, Lone Star Heart Inc, Centenary Institute, the Heart Research Institute, Cardiodirect (UK) Limited, the Woolcock Institute of Medical Research and the George Institute of International Health. He was also Editor-in-Chief of the International Journal of Cardiology for nearly 20 years.

Presently, Professor Coats is serving as Joint Academic Vice-President of Monash University, Australia and the University of Warwick, UK. He is President of the Heart Failure Association of the European Society of Cardiology and is Editor-in-Chief of Cardiac Failure Review.


Career Timeline

  • 1991: Senior Lecturer, National Heart and Lung Institute
  • 1996 - 2002: Viscount Royston Professor of Cardiology, Imperial College London
  • 1998 - 2000: Director of Cardiology, Royal Brompton Hospital
  • 1999 - 2015: Editor-in-Chief, International Journal of Cardiology
  • 2000 - 2002: Associate Medical Director, Royal Brompton Hospital
  • 2002 - 2006: Dean of Medicine, University of Sydney
  • 2006 - 2010: Deputy Vice-Chancellor, University of Sydney
  • 2009: Second Norwich Research Park Professor-at-Large
  • 2009 - 2010: Director, Cardiodirect
  • 2010 - 2012: The Norwich Research Park Professor and Chief Executive, NRP and UEA
  • 2011 - 2012: CEO, Norwich Research Park
  • 2011 - 2017: Director, Lone Star Heart Inc.
  • 2013 - 2016: Academic Vice-President (Monash/Warwick Alliance), Monash University
  • 2020 - Present: President, Heart Failure Association
  • 2020 - Present: President-Elect, Presidential Trio of the Heart Failure Association of the ESC
  • Present: Editor-in-Chief, Cardiac Failure Review



  • 1998: Linacre Medal of the Royal College of Physicians 
  • 1999: The Inaugural Michael L Pollock Award, American Heart Association 
  • 2010: Gold Heart Award, American Heart Association
  • 2017: Officer of the Order Of Australia


Areas of Speciality1

  • Chronic heart failure
  • Hypertension
  • Organizational behaviour



  1. https://www.radcliffecardiology.com/authors/andrew-js-coats 
  2. https://en.wikipedia.org/wiki/Andrew_Stewart_Coats#Early_life_and_education 
  3. https://www.radcliffe-group.com/our-team/
  4. https://web.archive.org/web/20110217131215/http://www.msmr.nsw.gov.au/__data/page/21/NSW_Research_-_A_Prescription_for_Health.pdf
  5. https://www.monash.edu/about/structure/senior-staff/andrew-coats 
  6. https://peoplepill.com/people/andrew-coats-1
  7. https://esc365.escardio.org/Person/34057-prof-coats-andrew 
  8. https://warwick.ac.uk/newsandevents/pressreleases/joint_vice-president_announced/ 
  9. https://www.monash.edu/news/articles/professor-andrew-coats-appointed-officer-of-the-order-of-australia
  10. https://www.gg.gov.au/sites/default/files/2019-12/ao_final_media_notes.pdf 


Prof Coats is Editor-in-Chief of the Cardiac Failure Review editorial board. 



View full profile

Key References

1. Vitale C, Jankowska E, Hill L, et al. Heart Failure Association/European Society of Cardiology position paper on frailty in patients with heart failure. Eur J Heart Fail. 2019;21(11):1299-1305

2. Coats AJS. Heart failure management of the elderly patient: focus on frailty, sarcopaenia, cachexia, and dementia: conclusions. Eur Heart J Suppl. 2019;21(Suppl L):L36-L38.

3. Lyon AR, Dent S, Stanway S, et al. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society [published online ahead of print, 2020 May 28]. Eur J Heart Fail. 2020;10.1002

4. Habibian M, Lyon AR. Monitoring the heart during cancer therapy. Eur Heart J Suppl. 2019;21(Suppl M):M44-M49.

5. Anker MS, Hadzibegovic S, Lena A, et al. Recent advances in cardio-oncology: a report from the 'Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019'. ESC Heart Fail. 2019;6(6):1140-1148.

6. Filippo Crea, C. Noel Bairey Merz, John F. Beltrame, Juan Carlos Kaski, et. al. on behalf of the Coronary Vasomotion Disorders International Study Group (COVADIS), The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift, European Heart Journal, Volume 38, Issue 7, 14 February 2017, Pages 473–477

Load more